Correlation Between Eliem Therapeutics and Century Therapeutics

Can any of the company-specific risk be diversified away by investing in both Eliem Therapeutics and Century Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eliem Therapeutics and Century Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Eliem Therapeutics and Century Therapeutics, you can compare the effects of market volatilities on Eliem Therapeutics and Century Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eliem Therapeutics with a short position of Century Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eliem Therapeutics and Century Therapeutics.

Diversification Opportunities for Eliem Therapeutics and Century Therapeutics

0.61

Correlation Coefficient

Eliem Therapeutics  Century Therapeutics

Poor diversification

The 3 months correlation between Eliem and Century is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Eliem Therapeutics and Century Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Century Therapeutics and Eliem Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eliem Therapeutics are associated (or correlated) with Century Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Century Therapeutics has no effect on the direction of Eliem Therapeutics i.e., Eliem Therapeutics and Century Therapeutics go up and down completely randomly.

Pair Corralation between Eliem Therapeutics and Century Therapeutics

Given the investment horizon of 90 days Eliem Therapeutics is expected to under-perform the Century Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Eliem Therapeutics is 1.06 times less risky than Century Therapeutics. The stock trades about -0.24 of its potential returns per unit of risk. The Century Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  164.00  in Century Therapeutics on September 1, 2024 and sell it today you would earn a total of  8.00  from holding Century Therapeutics or generate 4.88% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	98.41%
Values	Daily Returns

Eliem Therapeutics  vs.  Century Therapeutics

Eliem Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Eliem Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.

Century Therapeutics

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Century Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Century Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Eliem Therapeutics and Century Therapeutics

The main advantage of trading using opposite Eliem Therapeutics and Century Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eliem Therapeutics position performs unexpectedly, Century Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Century Therapeutics will offset losses from the drop in Century Therapeutics' long position.

The idea behind Eliem Therapeutics and Century Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.